Allianz Asset Management GmbH - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 18 filers reported holding PTC THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$2,156,000
-37.8%
2,000,000
-33.3%
0.00%
-33.3%
Q1 2021$3,467,000
-58.1%
3,000,000
-53.3%
0.00%
-62.5%
Q4 2020$8,271,000
+12.8%
6,420,0000.0%0.01%
-11.1%
Q3 2020$7,330,000
-71.9%
6,420,000
-71.6%
0.01%
-70.0%
Q2 2020$26,066,000
+2.8%
22,580,000
-3.0%
0.03%
-11.8%
Q1 2020$25,354,000
+33.4%
23,270,000
+40.8%
0.03%
+100.0%
Q4 2019$19,009,000
+22.9%
16,525,000
+11.2%
0.02%
+13.3%
Q3 2019$15,464,000
-42.4%
14,865,000
-38.6%
0.02%
-40.0%
Q2 2019$26,843,000
-18.1%
24,205,000
-23.6%
0.02%
-21.9%
Q1 2019$32,786,000
+8.9%
31,695,000
+3.7%
0.03%
-3.0%
Q4 2018$30,097,000
-8.0%
30,570,000
+9.1%
0.03%
+10.0%
Q3 2018$32,702,000
+91.7%
28,025,000
+62.5%
0.03%
+76.5%
Q2 2018$17,056,000
+1726.1%
17,250,000
+1625.0%
0.02%
+1600.0%
Q1 2018$934,000
+20.7%
1,000,0000.0%0.00%0.0%
Q4 2017$774,000
-51.8%
1,000,000
-50.0%
0.00%0.0%
Q3 2017$1,606,0002,000,0000.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 24,877,000$25,902,0001.06%
PFM Health Sciences, LP 19,807,000$20,605,0000.61%
Partner Investment Management, L.P. 193,000$201,0000.34%
DeepCurrents Investment Group LLC 4,430,000$4,581,0000.31%
WOLVERINE ASSET MANAGEMENT LLC 20,454,000$21,253,0000.27%
FARALLON CAPITAL MANAGEMENT LLC 24,176,000$25,210,0000.19%
PALISADE CAPITAL MANAGEMENT, LP 2,300,000$2,381,0000.07%
Verition Fund Management LLC 1,415,000$1,472,0000.04%
CAPSTONE INVESTMENT ADVISORS, LLC 4,298,000$4,470,0000.03%
LOOMIS SAYLES & CO L P 248,482$8,404,0000.02%
View complete list of PTC THERAPEUTICS INC shareholders